Navigation Links
NexMed Announces Completion of Patient Enrollment in Two Pivotal,Phase 3 Studies for Anti-Fungal Product

EAST WINDSOR, N.J.--(BUSINESS WIRE)--July 9, 2007 - NexMed, Inc. (NASDAQ: NEXM), a developer of innovative transdermal treatments based on the NexACT(R) drug delivery technology, today announced that Novartis Pharma AG has completed patient enrollment for Phase III clinical trials for NM100060, a topical treatment for onychomycosis (nail fungus). Pursuant to the terms of the licensing agreement with Novartis, NexMed will be entitled to a milestone payment early next year. NexMed entered into an exclusive, worldwide agreement with Novartis in September 2005, under which Novartis assumed all clinical development, regulatory, manufacturing and commercialization responsibilities for NM10060.

NM100060 is a topical application of Lamisil(R) (terbinafine), formulated with terbinafine and the Company's patented NexACT permeation enhancer, which facilitates the delivery of the drug into the nail bed, where the fungus resides.

About NexMed

NexMed, Inc. is an emerging drug developer that is leveraging its proprietary drug technology to develop a significant pipeline of innovative pharmaceutical products to address significant unmet medical needs. The Company is also working with various pharmaceutical companies to explore the incorporation of NexACT(R) into their existing drugs as a means of developing new patient-friendly transdermal products and extending patent lifespans and brand equity. For further information about the Company, go to www.nexmed.com.

Statements under the Private Securities Litigation Reform Act: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to its ability to maintain reduced expenditures, enter into partnering agreements, pursue growth opportunities, and/or
'"/>




Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:1/15/2014)... , Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) ... November 30, 2013, compared to sales of $2,202,000 for the ... again, this quarter has also shown growth over the preceding ... quarter of this fiscal year. Markets that experienced sales increases ...
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules -- HARBIN, China, Aug. 19 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... 18 GeneLink, Inc. (OTC Bulletin Board: ... for the fiscal quarter ended June 30, 2010. ... operating loss reduced by 35% over Q2 2009 Comparable quarter ... Month Revenues of $4,240,177 compared to $4,085,215 in the first six ...
Cached Medicine Technology:Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 2Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 3Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 4Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 5Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 6Renhuang Receives Patent for Product Package Design for Compound Honeysuckle Granules 7GeneLink Reports Second Quarter Improvement 2
(Date:7/10/2014)... July 10, 2014 Ticketability.com has a wide ... now Paul McCartney tickets for San Diego are being added ... Diego since 1976, and the newly added September 28 show ... , Click Here to view the selection of ... Petco Park will become available to the general public on ...
(Date:7/10/2014)... July 10, 2014 CBPartners, a global ... has launched a new website. The redesigned site ... increased access to the firm’s thought pieces, blog posts, ... ideal platform to showcase our insights, capabilities, and to ... CBPartners’ Chief Executive Officer, Cyrus Chowdhury. “An enhanced ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 ... the latest results of the 4th “Trending in ... suite model. , Every day multinational corporations ... contracts, expense forms etc. To meet this challenge, ... (S2P) suites which can be defined as a ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Adults with dyslexia are ... as children or teenagers than people who don,t have ... Dyslexia, which affects up to 10 percent of ... that 35 percent of adults with this condition said ... 7 percent of those without dyslexia. "Even after ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, ... make use of calorie information on menus, if it,s available, ... new U.S. study. Women in particular review the menu ... epidemiologist with the U.S. Centers for Disease Control and Prevention. ... labeling to help choose their meal, compared with just under ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:CBPartners Announces New Website 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 2Health News:‘Source-to-Pay’ e-Procurement Is Real Performance Driver for Purchasing Departments 3Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3
... Pa., March 2 Herley Industries, Inc. (Nasdaq: ... received contract awards totaling approximately $1 million from the U. ... assemblies and radar components. The awards are for the ... the B1 Bomber and radar components for use in the ...
... MEMPHIS, Tenn., March 2 Accelerated Community Oncology ... announced today the highlights of its annual Principal ... Medical oncologists from community-based oncology practices throughout ... cancer research advances, emerging treatment trends, as well ...
... Triple-S,Management Corporation (NYSE: GTS ) today announced ... Juan-Jose Roman, Finance Vice,President & CFO, will host an ... The presentation will be broadcast live through the ... access the webcast at the Triple-S,Management website at ...
... brings experience as CIO and HIMSS executive; Shirley Hughes ... mobility companyHATBORO, Pa., March 2 InfoLogix, Inc. ... provider of enterprise mobility solutions for the healthcare and ... has joined Healthcare Informatics Associates (HIA), an ...
... Pa., March 2 The first Eklin RapidStudy(TM),digital ... installed at Dr.,Flake,s Animal Wellness Clinic which serves ... The state-of-the-art system,from Eklin Medical Systems, the leader ... the area,s thousands of veterinary patients,supporting the Clinic,s ...
... March 2 Boston Scientific Corporation (NYSE: BSX ... elected John E. Sununu as a Director. For the ... from New Hampshire. He was a member of the ... was appointed the Congressional Representative to the United Nations General ...
Cached Medicine News:Health News:Herley Lancaster Awarded $1.0 Million in New Contracts 2Health News:ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting 2Health News:ACORN's Success in Delivering Top Quality Research Portfolio to Community-Based Oncology Practices Presented at Annual Investigator Meeting 3Health News:Triple-S Management Corporation to Host Inaugural Investor Day on March 5, 2009 2Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 2Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 3Health News:Industry Veterans Appointed to Key Leadership Posts at Healthcare Informatics Associates (HIA), an InfoLogix Company 4Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 2Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 2Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 4
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
... The NMP22 BladderChek Test is the only ... diagnosis of bladder cancer. The NMP22 BladderChek Test ... a single urine sample, that detects elevated levels ... small amounts of NMP22 protein in the urine. ...
... The NMP22® Test Kit is a quantitative ... NMP22 protein. Healthy individuals generally have very small ... the level of NMP22 protein is often elevated ... even at early stages of the disease. The ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
Medicine Products: